Cancer Control in the 21st Century with Special Attention to Disparities in Health
On December 23, 1971, President Richard Nixon signed the National Cancer Act. It was historic legislation aimed at overcoming one of man’s most dreaded disease. It is often referred to as the nation declaring war on cancer. The law infused unprecedented financial support into cancer research (basic and clinical). Numerous important questions have been asked and many answered. Indeed, the past fifty years have led to a change in our understanding of cancer. We have moved from a 19th century definition of cancer based on histology, to a 21st century definition based on histology and genomics.
Also of import, the law called for a cancer control program. A key part of which was a surveillance system that would establish and manage a program to determine cancer incidence, mortality, survival, and study patterns of cancer care. The surveillance program has documented the successes and failures of the National Cancer Act. It has stimulated the academic field of cancer epidemiology. The effort to control cancer has led to a 31 percent reduction in age-adjusted cancer death rate from 1991 to 2018. This decline is due to prevention (risk reduction), appropriate screening, diagnosis, and treatment. While there have been successes, all have not benefited equally. An efficient health system could have caused an even greater decline. The National Cancer Act stimulated the academic field of health disparities/health equity. Research suggests that more than 20 percent of the 600,000 cancer deaths per year are avertable in an efficient healthcare system.
The National Cancer Act has defined a number of questions pertinent to the control of cancer. Perhaps the most important question is: "How can we provide adequate, high-quality care, to all Americans.”
Видео Cancer Control in the 21st Century with Special Attention to Disparities in Health канала Fralin Biomedical Research Institute
Also of import, the law called for a cancer control program. A key part of which was a surveillance system that would establish and manage a program to determine cancer incidence, mortality, survival, and study patterns of cancer care. The surveillance program has documented the successes and failures of the National Cancer Act. It has stimulated the academic field of cancer epidemiology. The effort to control cancer has led to a 31 percent reduction in age-adjusted cancer death rate from 1991 to 2018. This decline is due to prevention (risk reduction), appropriate screening, diagnosis, and treatment. While there have been successes, all have not benefited equally. An efficient health system could have caused an even greater decline. The National Cancer Act stimulated the academic field of health disparities/health equity. Research suggests that more than 20 percent of the 600,000 cancer deaths per year are avertable in an efficient healthcare system.
The National Cancer Act has defined a number of questions pertinent to the control of cancer. Perhaps the most important question is: "How can we provide adequate, high-quality care, to all Americans.”
Видео Cancer Control in the 21st Century with Special Attention to Disparities in Health канала Fralin Biomedical Research Institute
Показать
Комментарии отсутствуют
Информация о видео
10 сентября 2021 г. 3:43:30
01:06:04
Другие видео канала
Mitochondria and Smooth Muscle Proliferation in Vascular DiseaseBrain School: Is the brain able to change or am I wired this way for life?The Neurobiology of Social Bonding, Empathy, and Social Loss: Implications of AutismWhat Each One of Us Can DoPersonalized, Personalized Medicine: Lessons Learned from Chasing My CureUntangling 22q11.2 Deletion Syndrome: The role of Ranbp1 in craniofacial and brain developmentChronic Metabolic AcidosisBehavioral Economic Approaches for Measuring Substance Use Severity and Motivating ChangeConnexin 43: A New Player in Duchenne Muscular Dystrophy and Associated CardiomyopathyEndophenotypes of Traumatic Brain InjuryDeciphering the Dynamics of the Unconscious Brain Under General Anesthesia2022 Health Sciences and Technology Hokie PitchModeling Endothelial Dysfunction in LMNA-related Dilated CardiomyopathyTranslational Investigations of Clostridioides difficile InfectionCRISPR-guided Therapeutic Discovery: First-in-Class Inhibitors of CHD4 for Glioblastoma#VTGivingDay: Thank YouFall 2021 HS&T Hokie PitchHypothesis-Generating Research and Predictive MedicineWelcome to the Fralin Biomedical Research InstituteCenter rhythm generator and central pain suppression circuits